e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Insights into paediatric bronchology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lane Hamilton Syndrome without gastrointestinal symptoms
T. Sismanlar Eyuboglu (Ankara, Turkey), G. Sahin (Ankara, Turkey), N. Eroglu (Ankara, Turkey), A. Fettah (Ankara, Turkey), A. Akca Caglar (Ankara, Turkey), H. Yucel (Ankara, Turkey), S. Senel (Anakara, Turkey)
Source:
International Congress 2019 – Insights into paediatric bronchology
Session:
Insights into paediatric bronchology
Session type:
Thematic Poster
Number:
1065
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Sismanlar Eyuboglu (Ankara, Turkey), G. Sahin (Ankara, Turkey), N. Eroglu (Ankara, Turkey), A. Fettah (Ankara, Turkey), A. Akca Caglar (Ankara, Turkey), H. Yucel (Ankara, Turkey), S. Senel (Anakara, Turkey). Lane Hamilton Syndrome without gastrointestinal symptoms. 1065
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Relationship between Hospital Anxiety and Depresion Scale (HADS) and clinical asthma control
Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Year: 2010
Sarcoidosis-associated fatigue
Source: Eur Respir J 2012; 40: 255-263
Year: 2012
The Hospital Anxiety and Depression Scale (HADS) in Bronchiectasis: Response to pulmonary rehabilitation (PR) and Minimum Clinically Important Difference (MCID)
Source: International Congress 2019 – Hot topics in pulmonary rehabilitation
Year: 2019
Severity of OSA and Depression
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019
Health-related quality of life in COPD: why both disease-specific and generic measures should be used
Source: Eur Respir J 2001; 18: 69-76
Year: 2001
Anxiety dyspnea
Source: Eur Respir J 2006; 28: Suppl. 50, 56s
Year: 2006
Respiratory symptoms – the only symptoms of achalasia
Source: Eur Respir J 2006; 28: Suppl. 50, 56s
Year: 2006
The prevention of postoperative respiratory complications in lung surgery
Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases
Year: 2014
Impact of symptoms of anxiety and depression on COPD Assessment Test scores
Source: Eur Respir J 2014; 43: 898-900
Year: 2014
Anxiety and depression in patients with asthma
Source: Annual Congress 2011 - Asthma: improving diagnosis and management for reaching better control
Year: 2011
Anxiety and depression in patients with asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 275s
Year: 2005
Anxiety and depression in patients with asthma
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Depression: a characteristic comorbidity of COPD?
Source: Eur Respir J 2014; 44: 570-571
Year: 2014
Role of the educational level on the self-assessment of somnolence by using the Epworth Sleepiness Scale Questionaire in patients with obstructive Sleep Apnea (OSA)
Source: International Congress 2017 – Diagnostic approaches to obstructive sleep apnoea
Year: 2017
Symptom palliation in COVID-19
Source: COVID-19 Videos
Year: 2020
Depression and anxiety in patients with COPD
Source: Eur Respir Rev 2014; 23: 345-349
Year: 2014
Depression in chronic obstructive pulmonary disease: Predictors and accuracy of the hospital anxiety and depression scale (HADS)
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014
Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis
Source: Eur Respir J 2012; 39: 899-905
Year: 2012
Fatigue changes in IPF patients measured by the Fatigue Assessment Scale during antifibrotic treatment
Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept